702 presents... The Moth

Gethwana Mahlase told her story to give hope to others - you should listen

Social activist Gethwana Mahlase is a nurse and NGO founder and told her story at the recent "702 presents The Moth" showcase event - to rapturous applause.

On 1 December South Africans will commemorate World Aids Day and Gethwana says much more needs to be done.

She gave up her day job as a nurse and, through hard work and determination started her NGO in 1995.

She lost friends and relatives to HIV/AIDS and started working in her community to address mens' role and women's rights in fighting the disease.

Mahlase spent many years as a community HIV/AIDS educator in rural Kwa-Zulu Natal and is now writing a book on stories she collected from grandmothers who lost all or almost all their children to the illness.

We have not yet won the fight. We are not yet where we want to be.

Gethwana Mahlase, social activist

She believes that NGOs have an important role to play in advocating for HIV/AIDS and providing support to communities.

According to Mahlase, the stigma of HIV/AIDS still exists but has become internalised HIV positive people.

It's not so much that people from the outside that stigmatise. It's the people themselves who are afraid and carry internal fears.

Gethwana Mahlase, social activist

She says the perception of risk has been reduced over the years due to the development of ARV treatment and other drugs.

Gethwana was one of the storytellers featured in our podcast series "702 presents The Moth". Her story received a massive response when she told it at the Market Theatre.

702 partnered with The Moth to present unique story podcasts around issues of personal identity and experiences with HIV/ AIDS.

Click here for access to the entire archive of HIV/ AIDS related podcasts from "702 presents... The Moth".

Learn more about The Moth - an acclaimed non-for-profit organisation dedicated to the art and craft of storytelling.

Read More

South Africa launches world's largest HIV vaccine study in seven years

South Africa has launched the largest and most advanced HIV vaccine clinical trial to help prevent HIV infections.

Medical experts optimistic about new HIV vaccine

The largest and most advanced HIV vaccine clinical trial is set to take place in South Africa.

SA historic clinical trial for HIV vaccine gives hope

The nationwide trial holds promise for a breakthrough in HIV that continues to affect millions of South Africans.

TAC says govt may be ill-equipped to roll out ARVs for all

ARVs will soon be accessible all HIV+ patients, irrespective of their CD4 count. But the Treatment Action Campaign has its doubts.

TAC questions government's readiness for test and treament programme

TAC concerned that the number of people illegible to receive ARV's is going to increase, and asks will government manage them all?

Gail Johnson: Response to HIV treatment would make Nkosi Johnson proud

Gail Johnson says Nkosi Johnson's activism in the fight against HIV/Aids has been validated by a visit from Cyril Ramaphosa.

ARVs soon to be available to all HIV patients, irrespective of CD4 count

By September, anyone with HIV will be able to get antiretroviral treatment irrespective of their CD4 count.

New calls for medical aid schemes to pay for HIV prevention drugs

Medical aid companies stand to benefit from preventative HIV care packages for clients, says healthcare funder Dr Humphrey Zokufa.

Drugs will reduce risk of getting HIV - Health department on board

The use of ARV's as a pre-exposure drug has proved highly effective in reducing the risk of people contracting HIV.

'Life expectancy 10% higher since emergence of effective ARV treatment'

Effective treatment and scientific research is said to have had a positive effect on the life expectancy of those diagnosed with HIV.

Popular articles
Meet self-made millionaire (net worth – R400m!) property mogul Sisa Ngebulana

Meet self-made millionaire (net worth – R400m!) property mogul Sisa Ngebulana

How did Ngebulana build his empire? The Money Show’s Bruce Whitfield interviewed him for his weekly “ShapeShifter” feature.

6 ways the new UIF bill benefits workers

6 ways the new UIF bill benefits workers

The broadened bill will see those who lose their jobs receive money for a longer period when they apply for unemployment benefits.

It's not the end of the road... Top tips to improve your matric

It's not the end of the road... Top tips to improve your matric

"Recognise that it’s not the end, it’s the beginning." Expert advise for school-leavers who want to improve their results.

'I wanted lots of money!' - Andile Mazwai (National Stokvel Association of SA)

'I wanted lots of money!' - Andile Mazwai (National Stokvel Association of SA)

Bruce Whitfield interviews Stokvel Association CEO Andile Mazwai about his attitude to money (hopes, fears, successes, failures).

NSFAS to reopen 2017 applications

NSFAS to reopen 2017 applications

National Student Financial Aid Scheme says it will reopen 2017 loan applications after receiving requests for deadline extension.

Right now, these are the best shares to buy on the JSE (according to Adviceworx)

Right now, these are the best shares to buy on the JSE (according to Adviceworx)

Bruce Whitfield interviews a Portfolio Manager about what she believes are the hottest stocks right now.

3 easy questions could bag you R2000!

3 easy questions could bag you R2000!

WIN R2000! But only if you can prove you're a whiz of the MTN Biz Quiz by answering the following three questions...

Blesserfinder: Matching you with a sugar daddy near you

Blesserfinder: Matching you with a sugar daddy near you

Is social trend Blesserfinder, where girls are allegedly matching up with rich 'benefactors' in exchange for sex, a real thing?